Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 5.4B | 5.3B | 4.7B | 4.7B |
| Cost of revenue | — | — | — | — |
| Gross profit | — | — | — | — |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | 551M | 873M | 475M | 476M |
| Other operating expenses | -170M | -63M | 1M | -134M |
| Operating income | — | — | — | — |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | — | — | — | — |
| Other income expense | — | — | — | — |
| Pretax income | 2.1B | 800M | 1.7B | 1.6B |
| Tax provision | 511M | 274M | 575M | 604M |
| Net income | 1.6B | 526M | 1.1B | 974M |
| Basic EPS | 0.6 | — | — | — |
| Diluted EPS | 0.6 | — | — | — |
| Basic average shares | 2.4B | — | — | — |
| Diluted average shares | 2.5B | — | — | — |
| EBITDA | — | — | — | — |
| Net income from continuing op. | — | — | — | — |
| Minority interests | -2M | -4M | 3M | 1M |
| Preferred stock dividends | — | — | — | — |